| HOME >> BIOLOGY >> TECHNOLOGY |
A paper written by the researchers details their findings and has been published online by Science magazine. It will appear in the magazine's print publication on Feb. 8. Other members of the HMS team who contributed to the paper include Alan Engelman, Yair Benita and Ramnik J. Xavier.
About the Genome-wide RNAi Global Initiative
The Genome-Wide RNAi Global Initiative is an alliance of leading
international biomedical researchers, established to increase and
accelerate the utility of human genome-wide siRNA libraries. The RNAi
Global Initiative provides a forum for member institutions to share
research protocols, establish experimental standards and develop mechanisms
for exchanging and comparing screening data. Membership is open to
not-for-profit biomedical research institutions across North America,
Europe and Asia. The RNAi Global Initiative is being coordinated under the
auspices of the RNA Technologies product team within Thermo Fisher
Scientific. Its members include the Campbell Family Institute for Breast
Cancer Research at Princess Margaret Hospital and Samuel Lunenfeld Research
Institute at Mount Sinai Hospital, both with The University of Toronto;
Cancer Research UK (CRUK) at the London Research Institute and the
Institute of Cancer Research (ICR); The German Cancer Research Center
(DKFZ); Eppley Cancer Center at the University of Nebraska Medical Center;
Netherlands Cancer Institute (NKI); The Division of Pathway Medicine at the
University of Edinburgh Medical School; the University of Texas
Southwestern Medical Center; Yale University; the University of Texas M. D.
Anderson Cancer Center; the Cambridge Institute for Medical Research and
MRC Cancer Cell Unit; Fox Chase Cancer Center; Harvard Medical School;
Stanford University School of Medicine; British Columbia Cancer Research
Centre; Trinity College, Dublin; the Vrije University Medical Center;
Weizmann Ins
'/>"/>
| SOURCE Thermo Fisher Scientific Inc. Copyright©2008 PR Newswire. All rights reserved |